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Abstract (134 words) 42 
Compelling evidence demonstrates the external globus pallidus (GPe) plays a key role in processing 43 
sensorimotor information. An anatomical projection from the GPe to the dorsal striatum (dStr) has been 44 
described for decades. However, the cellular target and functional impact of this projection remain unknown. 45 
Using cell-specific transgenic mice, modern monosynaptic tracing techniques, and optogenetics-based 46 
mapping, we discovered that GPe neurons provide inhibitory inputs to direct- and indirect-pathway striatal 47 
projection neurons (SPNs). Our results indicate that the GPe input to SPNs arises primarily from Npas1-48 
expressing neurons and is strengthened in a chronic Parkinson’s disease (PD) model. Alterations of the GPe-49 
SPN input in a PD model argue for the critical position of this connection in regulating basal ganglia motor 50 
output, arguing that strengthening of GPe-SPN connection is maladaptive and may underlie the hypokinetic 51 
symptoms in PD. 52 
 53 
 54 
Significance statement 55 
An anatomical projection from the pallidum to the striatum has been described for decades, but little is known 56 
about its connectivity pattern. Glajch, Kelver, Hegeman et al., dissect the pre- and postsynaptic neurons 57 
involved in this projection and show its cell-specific remodeling and strengthening in Parkinsonian mice. 58 
Chemogenetic activation of Npas1+ GPe neurons that give rise to the principal pallidostriatal projection 59 
increases the time that the mice spend motionless. This argues that maladaptive strengthening of GPe-SPN 60 
connection underlies paucity of volitional movements, which is a hallmark of PD.  61 
 62 
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Introduction (502 words) 69 
The external globus pallidus (GPe) is involved in processing sensorimotor information (DeLong, 1971; 70 
Anderson & Horak, 1985; Mitchell et al., 1987; Jaeger et al., 1995; Kimura et al., 1996; Raz et al., 2000; Nambu 71 
et al., 2002; Arkadir et al., 2004; Turner & Anderson, 2005; Obeso et al., 2006; Kita, 2007; Tachibana et al., 72 
2011; Jin et al., 2014; Dodson et al., 2015; Mallet et al., 2016; Yoshida & Tanaka, 2016), and alterations in GPe 73 
function have been directly linked to motor symptoms in disorders such as Parkinson’s disease (PD) (Bergman 74 
et al., 1998; Hauber, 1998; Vitek et al., 2004; Rajput et al., 2008; Johnson et al., 2012; Vitek et al., 2012; Abedi 75 
et al., 2013). Consistent with its role in sensorimotor function, a growing body of literature suggests that the 76 
GPe projects to all basal ganglia nuclei (Parent & Hazrati, 1995; Mink, 1996; Bolam et al., 2000; Kita, 2007; 77 
Mallet et al., 2012). These findings argue for a central position of the GPe in the basal ganglia circuitry (see 78 
Hegeman et al., 2016 for review). 79 
A projection from the GPe to the dorsal striatum (dStr), the primary input center of the basal ganglia, 80 
was postulated over a century ago (Wilson, 1911; 1913), and its existence has since been confirmed in a variety 81 
of species (Nauta, 1979; Staines et al., 1981; Beckstead, 1983; Jayaraman, 1983; Staines & Fibiger, 1984; Smith 82 
& Parent, 1986; Shu & Peterson, 1988; Walker et al., 1989; Kita & Kitai, 1991; Shinonaga et al., 1992; 83 
Rajakumar et al., 1994; Shammah-Lagnado et al., 1996; Spooren et al., 1996; Nambu & Llinas, 1997; Bevan et 84 
al., 1998; Kita et al., 1999; Sato et al., 2000; Kita & Kita, 2001; Mallet et al., 2012). However, very little is 85 
known about the identities of the GPe neurons that provide this input or the postsynaptic neurons they target. 86 
A major impediment to our understanding of the pallidostriatal pathway arises from the cellular complexity in 87 
the dStr and the GPe, as each of these nuclei comprises several types of neurons (Kita, 2007; Kreitzer, 2009; 88 
Tepper et al., 2010; Mallet et al., 2012; Gittis et al., 2014; Abdi et al., 2015; Dodson et al., 2015). Therefore, it is 89 
evident that we need a systematic analysis to map the connectivity between specific pallidostriatal inputs and 90 
identified postsynaptic target neurons. Similarly, the relevance of the pallidostriatal pathway to basal ganglia 91 
function and dysfunction remains to be established. 92 
Taking advantage of recently developed cell- and circuit-specific tools, our study sought to delineate the 93 
connectivity patterns and physiological impacts of the distinct GPe inputs to dStr neurons and how these 94 
parameters are changed in a PD model. We found that GPe input to the dStr targeted striatal spiny projection 95 
neurons (SPNs) and interneurons (INTs). The GPe-SPN input arose primarily from Npas1-expressing (Npas1+) 96 
GPe neurons. Furthermore, the pallidostriatal input to SPNs was enhanced in a chronic lesion model of PD. 97 
These findings argue for the critical position of the GPe-SPN connection in regulating basal ganglia motor 98 
output and PD symptomatology. 99 
 100 
 101 
Materials and Methods 102 
Animals. All experiments detailed are in accord with the Institutional Animal Care and Use Committees 103 
(IACUCs) at Northwestern University, National Institute of Biological Sciences, and the Ethics Committee of 104 
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Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences and are in compliance with the 105 
NIH Guide to the Care and Use of Laboratory animals.  106 
Experiments were conducted with ChatCre, Drd1aCre, Drd1aeGFP, Drd1atdTomato, Drd2Cre, Drd2eGFP, 107 
Npas1Cre-2A-tdTomato, PvalbCre, R26LSL-ChR2(H134R)-eYFP, and R26LSL-tdTomato mice. The Drd1atdTomato mouse was a gift 108 
from Dr. Nicole Calakos (Duke University) (Shuen et al., 2008). The Npas1Cre-2A-tdTomato mouse (Hernandez et 109 
al., 2015) was generated by the Northwestern Transgenic and Targeted Mutagenesis Laboratory (Hernandez et 110 
al., 2015). All other mice were obtained from the MMRC (Gong et al., 2003; Gerfen et al., 2013) or Jackson 111 
Laboratory. Mice for all experiments were maintained on a C57BL/6 background. Both males and female 112 
hemizygous or heterozygous mice were used in this study. 113 
 114 
Drugs. CGP55845, R-CPP, NBQX disodium salt, picrotoxin, QX314-Cl, RuBi-GABA, SR95531, and TTX were 115 
obtained from Abcam. KMeSO4 and Na2-GTP were from ICN Biomedicals and Roche respectively. All other 116 
reagents were obtained from Sigma Aldrich. Drugs were dissolved as stock solutions in either water, DMSO, or 117 
aCSF and were aliquoted and frozen at –30 ºC prior to use. Each of the drugs was diluted to the appropriate 118 
concentrations by adding it to the perfusate immediately before the experiment. The final concentration of 119 
DMSO in the perfusate was ≤ 0.1%. 120 
 121 
Chronic dopamine depletion. Unilateral lesion of the nigrostriatal system was produced by 6-122 
hydroxydopamine HCl (6-OHDA) injection into the medial forebrain bundle (MFB) (Chan et al., 2011; Fan et 123 
al., 2012; Glajch et al., 2012; Heuer et al., 2012). Mice at postnatal day 28–35 were anesthetized with 124 
isoflurane and immobilized on a stereotaxic frame (David Kopf Instruments). A small craniotomy (~1 mm 125 
diameter) was made with a dental drill (Osada) for injection into the MFB (at AP –0.7 mm and ML +1.1 mm 126 
from bregma, DV –4.8 mm from the dura). 6-OHDA (2.5 μg/μl) was dissolved in 0.9% wt/vol NaCl with 0.1% 127 
wt/vol ascorbic acid and 1 μl was injected using a calibrated glass micropipette (VWR) at a rate of 0.3–0.5 128 
μl/min. The micropipette was left in situ for 5–10 min post-injection to maximize tissue retention of 6-OHDA 129 
and decrease capillary spread upon pipette withdrawal. At three weeks after 6-OHDA injection, the cylinder 130 
test was used to quantify impairment in forelimb usage as an assessment for the degree of dopamine depletion 131 
(Schallert et al., 2000). All initial contacts made by each forepaw on the wall of a clear glass cylinder (9 cm 132 
diameter) during spontaneous exploratory behavior were counted during a 5-min period. Mice with fewer than 133 
20 total touches were excluded due to incomplete lesion. Asymmetry of the forelimb usage was expressed as 134 
‘limb-use asymmetry ratio’: independent contralateral forepaw placement relative to that of the ipsilateral (to 135 
the lesion) forepaw against the wall of the chamber during rearing and vertical or lateral explorations (Glajch et 136 
al., 2012). Electrophysiological experiments were performed 4–6 weeks after 6-OHDA injection. 137 
 138 
Viruses and injection procedures. Adeno-associated virus (AAV) were obtained from was obtained from 139 
University Pennsylvania Viral Vector Core and the University of North Carolina at Chapel Hill Gene Therapy 140 
Center Vector Core. Constitutive, pan-neuronal hSyn-hChR2(H134R)-eYFP (3.6 × 1013 genomic copies/ml) and 141 
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Cre-inducible expression (CreOn) EF1α-DIO-hChR2(H134R)-eYFP (0.7 × 1013 genomic copies/ml) AAVs 142 
serotype 9 were diluted in sterile PBS to their final titer and were injected into the GPe (135 nl at AP –0.46 mm, 143 
ML +1.97 mm, DV –4.0 mm from bregma) alone or concomitantly with MFB 6-OHDA injections (see above). 144 
CreOn hSyn-DIO-hM3Dq-mcherry (5.7 × 1012 genomic copies/ml) AAV serotype 8 was not further diluted and 145 
was injected bilaterally into the GPe (135 nl at AP –0.35 mm, ML ±2.2 mm, DV –3.6 mm and –4.1 mm from 146 
bregma). Viruses and procedures for monosynaptic retrograde labeling have been previously described (Guo et 147 
al., 2015).  148 
 149 
Immunohistochemistry. Mice aged postnatal day 55–80 were anaesthetized deeply with a ketamine-150 
xylazine mixture and perfused transcardially first with PBS or 0.9% saline solution followed by fixative 151 
containing 4% paraformaldehyde, pH 7.4. Tissue was then postfixed in the same fixative for an hour at 4 ºC. 152 
Tissue blocks containing the dStr and the GPe were sectioned using a vibrating microtome (Leica Instrument) 153 
at a thickness of 50–70 µm. Floating sections were blocked with 2.5–10% (vol/vol) normal goat or donkey 154 
serum (Gibco) and 0.1% (vol/vol) Triton X-100 in PBS for 30–60 min and subsequently incubated with 155 
primary antibodies in the same solution for 16–24 hrs at 4 °C. Primary antibodies used in this study include: 156 
GFP (Abcam, 1:1,000), HuCD (Life Technologies, 1:1,000), parvalbumin (Synaptic Systems, 1:500), RFP 157 
(Abcam, 1:500), and vesicular GABA transporter (Synaptic Systems, 1:500). After washes in PBS, the sections 158 
were incubated with Alexa-conjugated IgG antibody (Molecular Probes) at room temperature for 2 hours. The 159 
sections were then washed, mounted, and coverslipped. Immunoreactivity was examined on laser-scanning 160 
confocal microscope (Olympus Optical). For axonal density measurements, a region of interest (ROI) was 161 
selected at a comparable position for each striatal section. Background fluorescence was then subtracted from 162 
each pixel in the ROI. Mean pixel intensities were subsequently measured and normalized to GPe fluorescence 163 
level in each mouse. For rabies virus-tracing experiments, image stacks of the GPe were acquired at 25× on a 164 
laser-scanning confocal microscope (Olympus Optical) and were then analyzed by two individuals, including 165 
one who was blinded to the experimental conditions. The number of retrogradely-labeled cells within the GPe 166 
and their expression of parvalbumin were determined by visual inspection of all three orthogonal planes in Fiji 167 
(Schindelin et al., 2012).  168 
 169 
Fluorescence-activated cell sorting and quantitative PCR. Experimental procedures and data 170 
processing for fluorescence-activated cell sorting (FACS) and quantitative PCR (qPCR) were similar to analysis 171 
in our previous studies (Sheets et al., 2011; Plotkin et al., 2014). Ex vivo slices were prepared as described 172 
above, striata were microdissected, and single-cell suspensions were generated using a combination of 173 
enzymatic and mechanical dissociation procedures. dSPNs and iSPNs were purified using FACS on a cell sorter 174 
(BD Biosciences), based on tdTomato or eGFP expression. Dead cells were excluded based on the 4′,6-175 
diamidino-2-phenylindole (DAPI) or propidium iodide labeling. Approximately 10,000 cells from each mouse 176 
were collected, lysed using RealTime ready Cell Lysis Buffer (Roche), stored at –80 ºC, and used for qPCR 177 
analysis. Immediately following total RNA isolation using RNAeasy Micro Kit (Qiagen), first strand cDNA 178 
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synthesis was performed using cDNA Supermix (Quanta Biosciences). cDNAs were then frozen at –20 ºC until 179 
used. Desalted primers were custom synthesized (Invitrogen) and intron-spanning whenever possible (Table 180 
1). qPCRs were run in triplicate using Fast SYBR Green Mastermix (Applied Biosystems) on a qPCR instrument 181 
(Roche Applied Science). Negative controls for contamination from extraneous and genomic DNA were run for 182 
every gene target. The cycling protocol consisted of 95 °C for 5 min followed by 45 cycles at 95 °C for 10 s, 60 °C 183 
for 10 s, and 72 °C for 10 s. The PCR cycle threshold (CT) values were determined by the maxima of the second 184 
derivative of the fluorescence response curves. Melting curves were performed to verify amplification of single 185 
PCR products. A weighted CT (see Table 1) was calculated from seven reference genes (Atp5b, Cyc1, Eif4a2, 186 
Gapdh, H2afz, Sdha, and Uchl1) for each cell sample based on their expression stability for normalization 187 
(Chan et al., 2012; Fan et al., 2012; Plotkin et al., 2013; Plotkin et al., 2014). The mRNA levels in each group of 188 
samples were characterized by their median values. Quantification of transcript expression changes was 189 
performed using the ΔΔCT method. Results were presented as fold changes relative to the median of their 190 
respective naïve controls. 191 
 192 
Visualized recording in ex vivo brain slices. Mice aged postnatal day 55–90 were anesthetized with a 193 
ketamine-xylazine mixture and perfused transcardially with ice cold artificial cerebrospinal fluid (aCSF) 194 
containing in mM: 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2.0 CaCl2, 1.0 MgCl2, 25 NaHCO3, and 12.5 glucose, 195 
bubbled continuously with carbogen (95% O2 and 5% CO2). The brains were rapidly removed, glued to the 196 
stage of a vibrating microtome (Leica Instrument), and immersed in ice-cold aCSF. Parasagittal slices 197 
containing the dStr and the GPe were cut at a thickness of 240 μm and transferred to a holding chamber where 198 
they were submerged in aCSF at 35 ºC for 30 minutes and returned to room temperature for recording. Slices 199 
were then transferred to a small-volume (~0.5 ml) Delrin recording chamber that was mounted on a fixed-200 
stage, upright microscope (Olympus Optical). Neurons were visualized using differential interference contrast 201 
optics (Olympus Optical), illuminated at 735 nm (Thor Labs), and imaged with a 60× water immersion 202 
objective (Olympus Optical) and a CCD camera (QImaging). SPNs and INTs in the sensorimotor region of the 203 
dStr were targeted in this study (McGeorge & Faull, 1989). SPNs were identified by somatic eGFP or tdTomato 204 
fluorescence examined under epifluorescence microscopy with a daylight (6,500 K) LED (Thor Labs) and an 205 
appropriate filter cube (Semrock) to identify pathway-specific SPNs (i.e., dSPNs and iSPNs) from Drd1a- and 206 
Drd2-BAC transgenic mice (Gong et al., 2003; Shuen et al., 2008; Chan et al., 2012). Additionally, SPNs were 207 
identified based on their membrane properties measured with a high chloride internal solution (see below). 208 
Specifically, membrane capacitance and membrane resistance of each cell were measured immediately after 209 
break-in using a monoexponential curve fitting of the transient current response to a +10 mV, 100 ms step 210 
from –80 mV in pClamp10 (Molecular Devices). Cells with a membrane capacitance typically > 90 pF and a 211 
membrane resistance of 150–400 MΩ were classified as SPNs. In a subset of recordings, Alexa 594 hydrazide 212 
(10–100 μM, Molecular Probes) was included in the pipette solution to confirm the identity of SPNs by 213 
visualizing the presence of spine-dense dendrites. INTs were classified as cells with aspiny dendrites, 214 
membrane capacitances < 90 pF, and membrane resistances < 150 MΩ or > 400 MΩ. Fast-spiking 215 
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interneurons were identified by their somatic tdTomato fluorescence signal in the PvalbCre;R26LSL-tdTomato mice. 216 
For GPe recordings in the Npas1Cre-2A-tdTomato and PvalbCre;R26LSL-tdTomato mice, the neuron identity and Cre 217 
recombinase expression were determined by the somatic tdTomato fluorescence signal. 218 
Recordings were made at room temperature (20–22 ºC) with patch electrodes fabricated from capillary 219 
glass (Sutter Instruments) pulled on a Flaming-Brown puller (Sutter Instruments) and fire polished with a 220 
microforge (Narishige) immediately before use. Pipette resistance was typically ~2–4 MΩ. For the dStr voltage-221 
clamp recordings, a high chloride internal solution was used. The high chloride internal solution contained the 222 
following (in mM): 120 CsCl, 10 Na2 phosphocreatine, 5 HEPES, 5 tetraethylammonium-Cl, 2 Mg2ATP, 1 223 
QX314-Cl, 0.5 Na3GTP, 0.25 EGTA, and 0.2% (wt/vol) biocytin, pH adjusted to 7.25–7.30 with CsOH. Alexa 224 
594 hydrazide (10–100 μM) was also included in a subset of the recordings for morphological identification of 225 
dStr neurons. For the subthalamic nucleus recordings, a low chloride internal solution was used. The low 226 
chloride internal solution contained the following (in mM): 125 CsMeSO3, 10 Na2 phosphocreatine, 5 HEPES, 5 227 
tetraethylammonium-Cl, 2 Mg2ATP, 1 QX314-Cl, 0.5 Na3GTP, 0.25 EGTA, and 0.2% (wt/vol) biocytin, pH 228 
adjusted to 7.25–7.30 with CsOH. For current-clamp recordings, the internal solution consisted of (in mM): 229 
135 KMeSO4, 10 Na2phosphocreatine, 5 KCl, 5 EGTA, 5 HEPES, 2 Mg2ATP, 0.5 CaCl2, 0.5 Na3GTP, pH adjusted 230 
to 7.25–7.30 with KOH. The liquid junction potential for this internal solution was ~7 mV and was not 231 
corrected for. Photocurrent recordings in GPe neurons were collected with either the high chloride voltage-232 
clamp internal solution or the current-clamp internal solution. All internal solutions had an osmolarity of ~300 233 
mOsm/l. Somatic whole-cell patch-clamp recordings were obtained with an amplifier (Molecular Devices). The 234 
signal for voltage clamp recordings was filtered at 1 kHz and digitized at 10 kHz with a digitizer (Molecular 235 
Devices). For current-clamp recordings, the amplifier bridge circuit was adjusted to compensate for electrode 236 
resistance and subsequently monitored. Stimulus generation and data acquisition were performed using 237 
pClamp10. 238 
For optogenetic and GABA uncaging experiments, blue (peak 450 nm) excitation wavelength from two 239 
daylight (6,500 K) LEDs (Thor Labs) was delivered to the tissue slice from both the 60× water immersion 240 
objective and the 0.9 NA air condenser with the aid of 520 nm dichroic beamsplitters (Semrock). The field of 241 
illumination is ~500–700 μm in diameter. The duration for all light pulses was 2 ms for optogenetic 242 
experiments and 10 ms for GABA-uncaging experiments. All recordings were made in the presence of R-CPP 243 
(10 µM) and NBQX (5 µM) to prevent confounding effects of incidental activation of glutamatergic inputs.  244 
Offline data analyses and curve fitting were done with MATLAB8 (MathWorks). A given event was 245 
considered a successful optogenetically-driven monosynaptic response only if the amplitude exceeded four 246 
times the standard deviation of the noise level in the inward direction and the response onset occurred within 247 
2–8 ms after the light pulse for the dStr recordings; for the subthalamic nucleus recordings using terminal field 248 
stimulation, this parameter was 0–6 ms, applied to outward currents. Only cells for which this success rate was 249 
> 25% were deemed to be bona fide ‘responding’ cells; all cells with success rates ≤ 25% were considered to be 250 
‘non-responding’ cells. Rise time 10–90% and decay time 5–95% are used throughout. All decay measurements 251 
were performed on the last event in a given stimulus series. In experiments in which direct comparisons of 252 
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inhibitory postsynaptic currents (IPSCs) were made between neuron pairs, data were excluded if the series 253 
resistance of the patch pipette differed by more than 20% between the two recordings. Paired-pulse ratios were 254 
calculated by dividing the averaged IPSC2 amplitude by the averaged IPSC1 amplitude.  255 
 256 
Anatomical analysis of GPe-SPN contacts. To visualize the somatodendritic morphology of SPNs, Alexa 257 
594 hydrazide (100 μM) was loaded into the cells via the patch pipette. Following the establishment of a whole-258 
cell recording (see above), eYFP and Alexa 594 were excited using a 488 nm laser (Coherent) and 561 nm laser 259 
(Coherent), respectively. Confocal stacks of eYFP signals and Alexa 594 signals were acquired with a spinning-260 
disk unit (Yokogawa) and an EMCCD (Photometrics). Instrument control and data acquisition were performed 261 
using SlideBook6 (Intelligent Imaging Innovations). To determine putative contacts formed between GPe 262 
axons and SPN dendrites, image stacks were visually inspected offline in Fiji by an individual blinded to the cell 263 
type and treatment conditions. Synaptic contacts were deemed to be bona fide only if GPe axons and SPN 264 
dendrites were in close apposition in all x (≤ 0.2 μm), y (≤ 0.2 μm), and z (≤ 0.6 μm) planes. Euclidean 265 
distances between the contacts and the center of the cell body were measured. Clustering analysis of GPe-SPN 266 
contacts was performed in MATLAB8 using a k-means clustering algorithm. 267 
 268 
Behavior. Assessment of motor behavior was accomplished using an automated home cage scoring system 269 
(Metris) (Van de Weerd et al., 2001). Behavioral testing was performed between 15:30 h and 18:30 h under 270 
dim light (60 lux). Male control Npas1-Cre mice and DREADD hM3Dq-infected Npas1-Cre mice were 271 
repeatedly tested for four consecutive weeks (acclimation, baseline, clozapine N-oxide (CNO), and vehicle) at 272 
one-week intervals. The control group of mice included naïve Npas1-Cre mice and sham injected Npas1-Cre 273 
mice. The acclimation trial for the mice took place at postnatal day 49–58. The mice received no systemic drug 274 
or vehicle injection in acclimation and baseline trials. For the CNO trial, the mice were given an intraperitoneal 275 
(i.p.) injection of CNO at 3 mg/kg ten min prior to behavioral assessment. For the vehicle trial, the mice were 276 
given an i.p. injection of saline only. Each behavioral trial was 20 minutes. The bottoms of the behavior cages 277 
were cleaned with 70% ethanol and new bedding was added prior to the testing of each mouse. ‘Time spent 278 
motionless’ was defined as periods when the mouse was in a sitting or lying position with the absence of 279 
movements for > 250 ms. Similar analyses were performed on a separate cohort (postnatal day 55–97) of 280 
naïve Npas1-Cre mice (n = 14) and naïve, wild type C57BL/6 mice (n = 19) for only a single trial. Durations of 281 
locomotion (P = 0.4775), climbing (P = 0.4997), rearing (P = 0.8128), and motionlessness (P = 0.2627) were 282 
not different between the groups. 283 
 284 
Statistical analyses. Statistical analyses were performed with MATLAB8 and Prism6 (GraphPad). Sample 285 
size (n value) is defined by the number of observations (i.e. cells, cell-pairs, synaptic contacts, ROIs, sections, 286 
or mice). No statistical method was used to predetermine sample size. Data in the main text are presented as 287 
median values ± median absolute deviations as measures of central tendency and statistical dispersion, 288 
respectively. Box plots are used for graphical representation of population data (Krzywinski & Altman, 2014; 289 
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Streit & Gehlenborg, 2014). The central line represents the median, the box edges represent the interquartile 290 
ranges, and the whiskers represent 10–90th percentiles. Normal distributions of data were not assumed. 291 
Comparisons for unrelated samples were performed using a Mann–Whitney U test at a significance level (α) of 292 
0.05. Wilcoxon signed-rank was used for pairwise comparisons for related samples with a threshold (α) of 0.05 293 
for significance. Fisher’s exact test was used for categorical data with a threshold (α) of 0.05 for significance. 294 
Unless < 0.0001, exact P values (two-tailed) are reported.  295 
 296 
 297 
Results  298 
GPe axons target projection neurons and interneurons in the dStr 299 
To examine the cellular connectivity between GPe and striatal neurons, optogenetics was employed in 300 
conjunction with whole-cell patch-clamp recording in adult ex vivo mouse brain slices (Figure 1a). Delivery of 301 
an adeno-associated virus (AAV) expressing a Channelrhodopsin-2 (ChR2)-eYFP fusion protein under a pan-302 
neuronal promoter yielded widespread infection in the GPe. In addition, this gave rise to eYFP-labeled axonal 303 
processes terminating throughout the dStr (Figure 1b). The VGAT-immunoreactive puncta on these axons 304 
suggest that they have the capacity to release GABA within the dStr (Figure 1b). Because of their dense 305 
arborization in the dStr, we hypothesized that they target SPNs, the principal neurons of the dStr. In support of 306 
this idea, ultrastructural data suggest that pallidostriatal terminals are juxtaposed to spine-bearing dendrites in 307 
the dStr (Mallet et al., 2012). Consistent with our hypothesis, pan-neuronal optogenetic stimulation of the GPe 308 
(hereafter ‘pan-GPe’ input) elicited inhibitory postsynaptic currents (IPSCs) in SPNs (Figure 1c). In addition, 309 
optogenetic stimulation of the pan-GPe input evoked IPSCs in dStr INTs, which were identified by their aspiny 310 
dendrites (Figure 1c). The biophysical properties of the IPSCs recorded from SPNs and INTs were thus 311 
compared. While there was no difference in the synaptic latency, SPNs displayed a higher paired-pulse ratio 312 
(PPR, 20 Hz) (SPNs = 1.41 ± 0.23, n = 92 cells; INTs = 0.75 ± 0.16, n = 25 cells; P < 0.0001), longer rise time 313 
(SPNs = 5.9 ± 1.4 ms, n = 92 cells; INTs = 2.6 ± 1.0 ms, n = 25 cells; P < 0.0001), and longer decay time (SPNs 314 
= 217.0 ± 44.0 ms, n = 92 cells; INTs = 177.0 ± 41.6 ms, n = 25 cells; P = 0.0277) compared to INTs. These 315 
responses were abolished by application of the GABAA receptor antagonist SR95531 (10 μM) (Figure 1d), 316 
consistent with the GABAergic nature of the GPe (Fahn & Cote, 1968; Jessell et al., 1978; Oertel & Mugnaini, 317 
1984; Oertel et al., 1984).  318 
Parvalbumin-expressing (PV+) fast-spiking striatal interneurons (FSIs) are a subclass of INTs that play 319 
a pivotal role in regulating striatal functions (Koos & Tepper, 2002; Tepper & Bolam, 2004; Tepper et al., 320 
2008; Klaus et al., 2011; Gittis & Kreitzer, 2012) and were thus targeted in this analysis. In agreement with 321 
previous anatomical observations (Bevan et al., 1998; Mallet et al., 2012), activation of the pan-GPe input 322 
produced IPSCs in all FSIs examined (Figure 2). While there was no difference in the synaptic latency, SPNs 323 
displayed a higher PPR (SPNs = 1.30 ± 0.12, n = 12 cells; FSIs = 0.75 ± 0.16, n = 17 cells; P < 0.0001), longer 324 
rise time (SPNs = 5.2 ± 0.7 ms, n = 12 cells; FSIs = 2.8 ± 1.1 ms, n = 17 cells; P = 0.0015), and longer decay time 325 
(SPNs = 284.0 ± 35.9 ms, n = 12 cells; FSIs = 195.7 ± 46.7 ms, n = 17 cells; P = 0.0051) compared to FSIs from 326 
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the same animals. However, as FSIs account for only a small fraction of the total striatal INT population, it is 327 
very likely that additional subclasses of INTs also receive GPe input, as suggested by an earlier study (Bevan et 328 
al., 1998). 329 
 330 
GPe input targets both dSPNs and iSPNs 331 
As the balance in the activity of direct-pathway SPNs (dSPNs) and indirect-pathway SPNs (iSPNs) in the dStr is 332 
crucial for proper motor control (Albin et al., 1989; DeLong, 1990; Kravitz et al., 2010; Freeze et al., 2013; 333 
Calabresi et al., 2014; Sippy et al., 2015), it is important to further examine the functional connectivity of the 334 
pallidostriatal input to both populations of SPNs. To avoid the confounding effects of variable viral infection 335 
and inconsistent preservation of pallidostriatal axons in the slice preparation on the elicited responses, dSPNs 336 
and iSPNs within ~150 μm of each other were compared as dSPN-iSPN ‘pairs’ (see Materials and Methods). 337 
Identical stimulation site and light intensity were used for both neurons in each given paired recording. Using 338 
these conditions, iSPNs consistently exhibited larger IPSC amplitude compared to those from their dSPN 339 
matched pairs (iSPNs = 94.1 ± 30.0 pA, dSPNs = 52.5 ± 22.2 pA, n = 12 pairs; P = 0.0122). However, there was 340 
no difference in PPR (dSPNs = 1.58 ± 0.29, iSPNs = 1.47 ± 0.28, n = 11 pairs; P > 0.9999), rise time (dSPNs = 341 
6.8 ± 1.2 ms, iSPNs = 5.1 ± 1.0 ms, n = 11 pairs; P = 0.0537), or decay time (dSPNs = 253.4 ± 38.2 ms, iSPNs = 342 
210.6 ± 8.5 ms, n = 11 pairs; P = 0.2061) between dSPNs and iSPNs. Notably, the GPe-SPN IPSC population 343 
data are consistent with all of these findings (Table 2).  344 
 345 
Npas1+ neurons constitute the primary GPe input to SPNs 346 
The predominant projection from the GPe to the dStr has been proposed to originate primarily from PV-347 
negative (PV–) neurons (Kita & Kita, 2001; Hoover & Marshall, 2002; Mallet et al., 2012; Mastro et al., 2014). 348 
However, discordant results have been observed (Kita et al., 1999). As neurons that form the pallidostriatal 349 
projection are likely target cell-specific (Bevan et al., 1998), we used a monosynaptic rabies virus-tracing 350 
method (Ugolini, 2011; Callaway & Luo, 2015; Ghanem & Conzelmann, 2015) to examine the identity of the 351 
GPe neurons that synapse onto SPNs. 352 
To target dSPNs and iSPNs, Drd1a-Cre mice and Drd2-Cre mice were used, respectively (Figure 3a). 353 
Consistent with previous studies that employed rabies viruses to map cortical inputs to SPNs (Wall et al., 2013; 354 
Deng et al., 2015; Guo et al., 2015; Kim et al., 2015; Reardon et al., 2016), widespread, retrogradely-labeled 355 
neurons were evident in the cortex (Figure 3b). In addition, retrograde labeling of GPe neurons was also 356 
evident (Figure 3b), thus corroborating the electrophysiological analysis demonstrating that connections 357 
between GPe neurons and SPNs were monosynaptic. Furthermore, immunohistochemical staining for PV 358 
revealed that only a small fraction of these retrogradely-labeled GPe neurons were PV+ (0.0 ± 0.0%, n = 164 359 
cells). This is statistically different from the abundance of PV+ neurons in the total GPe population (55.3 ± 360 
6.2%, n = 1792 cells, P < 0.0001). As the expression patterns of PV and the transcription factor Npas1 in the 361 
GPe are segregated (Flandin et al., 2010; Nobrega-Pereira et al., 2010; Abdi et al., 2015; Hernandez et al., 362 
2015), we hypothesize that these SPN-targeting, PV– GPe neurons are largely Npas1+. 363 
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To this end, we used Pvalb-Cre (Hippenmeyer et al., 2005) and Npas1-Cre (Hernandez et al., 2015) 364 
transgenic lines to further assess the contribution of these two populations of GPe neurons to the pallidostriatal 365 
projection to SPNs. A CreOn ChR2-eYFP-expressing AAV was used to visualize the Npas1+ and PV+ GPe input 366 
to the dStr in Npas1-Cre mice and Pvalb-Cre mice, respectively. As illustrated in Figure 3c, Npas1+ GPe 367 
neurons exhibited widespread and dense axonal arborization within the dStr. On the other hand, the density of 368 
eYFP-labeled PV+ GPe axons was much lower (Npas1+ = 18.6 ± 5.7 a.u., n = 9 ROIs; PV+ = 4.3 ± 1.2 a.u., n = 9 369 
ROIs; P < 0.0001) (Figure 3d). As our ability to selectively express ChR2-eYFP in distinct GPe cell types 370 
(Npas1+ neurons vs. PV+ neurons) is crucial to our analysis, we assessed the presence of photocurrent in 371 
genetically-identified Npas1+ neurons and PV+ GPe neurons. Npas1+ GPe neurons in Npas1-Cre mice expressed 372 
photocurrent at the same percentage as PV+ GPe neurons did in Pvalb-Cre mice (Npas1-Cre = 91.7%, n = 12 373 
cells; Pvalb-Cre = 88.9%, n = 36 cells; P = 1.0000); photocurrent was observed in none of the non-Cre-374 
expressing GPe neurons (Npas1-Cre = 0 of 21 cells; Pvalb-Cre = 0 of 44 cells). Optogenetic stimulation of the 375 
PV+ GPe input yielded a smaller IPSC amplitude relative to the Npas1+ GPe input in both dSPNs (PV+ input = 0 376 
± 0 pA, n = 23 cells; Npas1+ input = 64.5 ± 21.6 pA, n = 27 cells; P < 0.0001) and iSPNs (PV+ input = 0 ± 0 pA, 377 
n = 13 cells; Npas1+ input = 138.2 ± 50.9 pA, n = 29 cells; P < 0.0001) (Figure 3d). This is consistent with the 378 
observations that GPe PV+ neurons target primarily FSIs and other INTs but not SPNs in the dStr (Bevan et al., 379 
1998; Mastro et al., 2014). As only a small subset of SPNs sampled received the PV+ GPe input (see below), the 380 
median of IPSCs amplitude is zero.  381 
Given that Npas1+ GPe neurons appeared to constitute the main pallidostriatal input to SPNs, we 382 
further analyzed the Npas1+ GPe input to dSPN-iSPN pairs. Stimulation of Npas1+ GPe neurons yielded IPSCs 383 
in iSPNs with larger amplitude (iSPNs = 134.1 ± 40.3 pA; dSPNs = 55.3 ± 23.5 pA; n = 17 pairs; P = 0.0017) 384 
relative to IPSCs in dSPNs. In contrast, there was no difference in PPR (dSPNs = 1.18 ± 0.17; iSPNs = 1.26 ± 385 
0.13; n = 16 pairs; P = 0.6322), rise time (dSPNs = 5.6 ± 0.7 ms; iSPNs = 5.6 ± 1.1 ms; n = 16 pairs; P = 386 
0.2030), and decay time (dSPNs = 247.0 ± 50.1 ms; iSPNs = 234.1 ± 28.0 ms; n = 16 pairs; P = 0.5966) 387 
(Figure 3f–g). These findings largely recapitulated the differences seen with the pan-GPe input (Table 2), 388 
further demonstrating that the GPe input to SPNs arises primarily from Npas1+ GPe neurons. 389 
To further delineate the relative contribution of Npas1+ GPe neurons to the total pallidostriatal input to 390 
SPNs, a comparative analysis of the response rate of SPNs to different GPe inputs was performed. At the 391 
population level, over 90% of all recorded SPNs (dSPNs = 92.6%, n = 27 cells; iSPNs = 96.6%, n = 29 cells) 392 
received input from Npas1+ GPe neurons. In contrast, a much smaller fraction of recorded SPNs receive input 393 
from PV+ GPe neurons (dSPNs = 39.1%, n = 23 cells; iSPNs= 23.1%, n = 13 cells; P < 0.0001) (Figure 3h). As 394 
multiple SPNs (n = 6 ± 2 cells) were typically sampled from each mouse, the response rate of SPNs to GPe 395 
input was computed for each mouse. In agreement with the population data, the response rate of SPNs to 396 
Npas1+ GPe input across mice was consistently high (dSPNs = 100 ± 0%, n = 9 mice; iSPNs = 100 ± 0%, n = 9 397 
mice), whereas the response rate of SPNs to PV+ GPe input was low (dSPNs = 0 ± 33.4%, n = 6 mice; iSPNs = 0 398 
± 0%, n = 5 mice; P = 0.0002) (Figure 3h). To confirm that the relatively low response rate with viral-399 
mediated optogenetic stimulation of PV+ GPe neurons was not a result of unreliable ChR2 expression, 400 
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additional experiments were performed with a mouse line carrying a floxed-stop ChR2-eYFP allele driven by 401 
the Pvalb promoter. Experiments with this mouse line yielded similar results to those derived using the viral 402 
approach (9.1%, n = 11 cells; P = 0.1467). Lastly, as the GPe contains cholinergic GPe neurons (Gritti et al., 403 
2006; Nobrega-Pereira et al., 2010; Abdi et al., 2015; Hernandez et al., 2015) that have the potential to co-404 
release GABA (Tkatch et al., 1998; Saunders et al., 2015), their input to SPNs was examined with the ChAT-Cre 405 
and floxed-stop ChR2-eYFP mice. However, direct GABAergic input to SPNs from cholinergic GPe neurons was 406 
not detected (0%, n = 7 cells). Altogether, optogenetics-based mapping experiments corroborate the rabies 407 
tracing findings that Npas1+ GPe neurons constitute the primary pallidostriatal projection to both dSPNs and 408 
iSPNs. To demonstrate that the connection between Npas1+ GPe neurons and SPNs is monosynaptic, GABA 409 
transmission was monitored under conditions in which action potential propagation was blocked (with 1 µM 410 
tetrodotoxin and 100 µM 4-aminopyridine) (Petreanu et al., 2009). Terminal field stimulation of the Npas1+ 411 
GPe input successfully evoked IPSCs in 9 out of 9 SPNs, thus confirming the monosynaptic nature of this 412 
connection. 413 
We have previously observed a low density of axonal projections from the Npas1+ GPe neurons to the 414 
subthalamic nucleus neurons (STN) (Hernandez et al., 2015). To further investigate the differences in the 415 
projection characteristics of Npas1+ GPe neurons and PV+ GPe neurons, we examined the spatial relationship 416 
between VGAT and GPe-STN axons. As illustrated in Figure 4a, VGAT-immunoreactive puncta were 417 
associated with PV+ GPe-STN axons and Npas1+ GPe-STN axons. To assess the strength and prevalence of the 418 
connectivity of these axons with STN neurons, whole-cell voltage-clamp recordings were performed on STN 419 
neurons. Terminal field optogenetic activation of PV+ GPe input reliably evoked large IPSCs with a low-chloride 420 
internal solution in 17 out of 18 (94%) STN neurons examined, while 11 out of 16 (~70%) of STN neurons 421 
responded to Npas1+ GPe input, with IPSCs that were over an order of magnitude smaller (PV+ input = 738.0 ± 422 
409.0 pA, n = 18 cells; Npas1+ input = 40.3 ± 19.1 pA, n = 16 cells; P < 0.0001) (Figure 4b). These findings are 423 
consistent with previous literature indicating that PV+ GPe neurons constitute the principal GPe projection to 424 
the STN (Hoover & Marshall, 1999; 2002; Mastro et al., 2014; Abdi et al., 2015; Hernandez et al., 2015).  425 
 426 
GPe-SPN input is enhanced following chronic 6-OHDA lesion 427 
Compelling evidence suggests that pathological activity in the GPe contributes to motor symptoms in PD 428 
(Zaragoza et al., 1992; Hauber et al., 1998; Rajput et al., 2008; Johnson et al., 2012; Vitek et al., 2012; Abedi et 429 
al., 2013). In PD animal models, GPe neurons exhibit reduced firing rates ex vivo and in vivo (Filion & 430 
Tremblay, 1991; Mallet et al., 2008; Chan et al., 2011; Lemaire et al., 2012; Hernandez et al., 2015). Since the 431 
imbalance in information processing between the direct and indirect dStr projection pathways has been 432 
strongly linked to motor symptoms in PD (Albin et al., 1989; DeLong, 1990; Kravitz et al., 2010), it is 433 
important to determine the physiological effects of chronic dopamine depletion on pallidostriatal signaling in 434 
SPNs. In this study, we employed unilateral stereotaxic lesions of the nigrostriatal pathway using the injection 435 
of the neurotoxin 6-hydroxydopamine (6-OHDA). 6-OHDA injected mice that exhibited sensorimotor 436 
behavioral deficits associated with a near-complete chronic unilateral lesion of the nigrostriatal pathway (Chan 437 
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et al., 2011; Chan et al., 2012; Glajch et al., 2012) were used to assess the physiological properties of the 438 
pallidostriatal input. 439 
An increase in the IPSC amplitude of the pan-GPe input to dSPNs (naïve = 56.9 ± 19.1 pA, n = 35 cells; 440 
6-OHDA = 99.8 ± 47.2 pA, n = 19 cells; P = 0.0285) and iSPNs (naïve = 89.5 ± 41.4 pA, n = 47 cells; 6-OHDA = 441 
240.4 ± 98.8 pA, n = 36 cells; P < 0.0001) was observed following chronic 6-OHDA lesion (Figure 5a & c). 442 
Similarly, there was an increase in IPSC amplitude of the Npas1+ GPe input to both dSPNs (naïve = 64.5 ± 21.6 443 
pA, n = 27 cells; 6-OHDA = 164.7 ± 91.0 pA, n = 20 cells; P = 0.0036) and iSPNs (naïve = 138.2 ± 50.9 pA, n = 444 
29 cells; 6-OHDA = 311.3 ± 194.2 pA, n = 29 cells; P = 0.0026) in chronic 6-OHDA lesioned mice (Figure 5b 445 
& d). The IPSC amplitude of the PV+ GPe input to iSPNs increased (naïve = 0 ± 0 pA, n = 13 cells; 6-OHDA = 446 
46.8 ± 46.8 pA, n = 20 cells; P = 0.0367) following chronic 6-OHDA lesion, but there was no alteration of the 447 
PV+ GPe input to dSPNs (naïve = 0 ± 0 pA, n = 23 cells; 6-OHDA = 37.6 ± 37.6 pA, n = 11 cells; P = 0.2282). 448 
When neighboring dSPNs and iSPNs were compared as matched pairs, we found that chronic 6-OHDA lesion 449 
did not alter the relative strength of the GPe input to iSPNs and dSPNs, as represented by the ratio of the IPSC 450 
amplitudes of iSPNs to those of dSPNs (pan-GPenaïve = 1.53 ± 0.39, n = 11 pairs; pan-GPe6-OHDA = 3.94 ± 1.42, n 451 
= 11 pairs; P = 0.1007; Npas1+ inputnaïve = 2.04 ± 0.89, n = 16 pairs; Npas1+ input6-OHDA = 1.76 ± 0.44, n = 14 452 
pairs; P > 0.9999). Additionally, using the proportion of responder neurons as a metric, no alteration in the 453 
gross connectivity pattern to SPNs before and after chronic 6-OHDA lesion was observed for Npas1+ GPe input 454 
(naïve = 94.6%, n = 56 cells; 6-OHDA = 93.9%, n = 49 cells; P = 1.0000). However, more SPNs responded to 455 
PV+ GPe input after chronic 6-OHDA lesion (naïve = 29.4%, n = 34 cells; 6-OHDA= 58.1%, n = 31 cells; P = 456 
0.0255). Furthermore, IPSC amplitude from the pan-GPe input to PV+ FSIs was also not altered following 457 
chronic 6-OHDA lesion (naïve = 600.7 ± 491.5 pA, n = 17 cells; 6-OHDA = 868.7 ± 530.1 pA, n = 31 cells; P = 458 
0.1054). 459 
   460 
GPe input dampens SPN output in chronic 6-OHDA lesioned mice 461 
Our data firmly established a connection between the GPe and SPNs. However, the functional role of this 462 
inhibitory pathway has not been illustrated. The prevailing circuit model predicts that the loss of dopaminergic 463 
input to the basal ganglia in PD creates an imbalance in the output of SPNs (Albin et al., 1989). Because of the 464 
GABAergic nature of the GPe-SPN input, strengthening of this connection should dampen SPNs’ output.  465 
 To assay the functional impact of the GPe-SPN input, we measured its effect on SPN firing driven by 466 
current injection. In the absence of optogenetic stimulation, naïve iSPNs were more excitable than naïve 467 
dSPNs, consistent with previous studies (Kreitzer & Malenka, 2007; Gertler et al., 2008; Chan et al., 2012; 468 
Fieblinger et al., 2014). As severing of axons is a common problem with all ex vivo slice preparations, we 469 
stimulated the terminal field of the pallidostriatal axons to recruit the maximum number of synapses 470 
distributed across the entire somatodendritic axis of the recorded SPNs (Gertler et al., 2008). In keeping with 471 
the GABAergic nature of the GPe-SPN input, its activation suppressed firing in SPNs. This action was abolished 472 
upon the application of GABAA receptor antagonists (SR95531 and picrotoxin) (Figure 5e). To avoid the 473 
confounding effects associated with unintentional activation of local striatal neurons, only the GPe was 474 
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stimulated in subsequent experiments. We found that dSPNs and iSPNs from both naïve and chronic 6-OHDA 475 
lesioned mice exhibited a decrease in firing in response to the pan-GPe input (Figure 5e-f). Importantly, 476 
iSPNs from chronic 6-OHDA lesioned mice exhibited a larger reduction in firing compared to the effect seen in 477 
naïve iSPNs (naïve = 94.0 ± 3.1%, n = 10 cells; 6-OHDA = 85.5 ± 3.8%, n = 6 cells; P = 0.0017) (Figure 5e-f). 478 
Similarly, 6-OHDA dSPNs also yielded a larger reduction in firing compared to the response in naïve dSPNs 479 
(naïve = 95.1 ± 3.6%, n = 10 cells; 6-OHDA = 87.1 ± 3.8%, n = 6 cells; P = 0.0415).  480 
 481 
GPe inputs to dSPNs and iSPNs are enhanced via distinct mechanisms 482 
What could explain the enhancement of the GPe input following chronic 6-OHDA lesion? One possible 483 
explanation for the slow kinetics of the pallidostriatal response in SPNs (relative to INTs) is that it originates in 484 
the dendrites. If this is correct, then a shift in the location of the GPe-SPN synapses toward more proximal sites 485 
or even somatic regions would explain the increased amplitude of the IPSCs measured with patch electrodes at 486 
the soma. To examine this possibility, we investigated the spatial relationship between GPe axons and SPN 487 
dendrites in ex vivo tissue slice using spinning-disk confocal microscopy. As illustrated in Figure 6a–b, 488 
apposition of GPe axons to dendrites of dSPNs and iSPNs was readily observed. By examining the branching 489 
structures of SPN dendrites, we discovered that approximately 90% of all GPe-SPN contacts were formed on 490 
the secondary (dSPNs = 46.3%, n = 31 contacts; iSPNs = 43.9%, n = 47 contacts), tertiary (dSPNs = 38.8%, n = 491 
26 contacts; iSPNs = 23.4%, n = 25 contacts), and quaternary (dSPNs = 7.5%, n = 5 contacts; iSPNs = 4.7%, n = 492 
5 contacts) dendrites (Figure 6c). Contacts on somatic regions (dSPNs = 1.5%, n = 1 contact; iSPNs = 18.7%, n 493 
= 20 contacts) and primary dendrites (dSPNs = 4.5%, n = 3 contacts; iSPNs = 9.3%, n = 10 contacts) of SPNs 494 
were scarce. The relative distribution of GPe-SPN contacts in different subcellular compartments differs 495 
between dSPNs and iSPNs (P = 0.0039). 496 
Additionally, the positions of contacts made by GPe axons along the somatodendritic axis of SPNs were 497 
determined by their Euclidean distance from the soma. We found that GPe-iSPN contacts were located closer 498 
to the soma than GPe-dSPN contacts (dSPNs = 52.0 ± 10.4 μm, n = 67; iSPNs = 39.9 ± 15.0 μm, n = 107 499 
contacts; P < 0.0001), consistent with the larger and faster pallidostriatal IPSCs in iSPNs relative to dSPNs. 500 
Furthermore, we observed that GPe-SPN contact locations were closer to the cell body of dSPNs following 501 
chronic 6-OHDA lesion (naïve = 52.0 ± 10.4 μm, n = 67 contacts; 6-OHDA = 48.4 ± 9.2 μm, n = 18 contacts; P 502 
= 0.0363). This shift could explain the increase in the strength of the pallidostriatal response in dSPNs. In 503 
contrast, GPe-SPN contact locations were shifted away from the cell body of iSPNs following chronic 6-OHDA 504 
lesion (naïve = 39.9 ± 15.0 μm, n = 107 contacts; 6-OHDA = 49.3 ± 14.7 μm, n = 38 contacts; P = 0.0367). This 505 
is unexpected given the enhancement of the pallidostriatal response amplitude observed in iSPNs following 506 
chronic 6-OHDA lesion. 507 
Given the difference in the extent of the enhancement of the pallidostriatal IPSCs in dSPNs and iSPNs 508 
after chronic 6-OHDA lesion, we hypothesized that postsynaptic mechanisms, such as upregulation of 509 
postsynaptic GABAA receptor expression, were involved. To this end, we performed qPCR analysis on FACS-510 
purified dSPNs and iSPNs in naïve and chronic 6-OHDA lesioned mice. This revealed that the transcript 511 
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expression of different GABAA receptor subunits in dSPNs was either decreased or unaltered with chronic 6-512 
OHDA lesion, further supporting our argument that the change in the location of the GPe synaptic contacts 513 
accounts for the increased GPe input to this cell type. In contrast, more complex changes were observed in 514 
iSPNs (Figure 7a). Of note, the upregulation of α2-subunit (1.33 ± 0.08 fold; P = 0.0330) and γ2-subunit 515 
(1.30 ± 0.12 fold; P = 0.0031) following chronic 6-OHDA lesion should promote surface—particularly 516 
synaptic—expression of GABAA receptors in iSPNs. The transcript abundance of different GABAA subunits in 517 
SPNs and their alterations following chronic 6-OHDA lesion are listed in Table 3. Furthermore, we have 518 
previously demonstrated that an increase in the expression of the γ2-subunit underlies the strengthening of the 519 
GPe-STN synapse following chronic 6-OHDA lesion (Fan et al., 2012). We employed GABA uncaging to assess 520 
the total surface expression of GABAA receptors on iSPNs to avoid any confounding presynaptic factors that 521 
would affect the responses. Consistent with our hypothesis, chronic 6-OHDA lesion resulted in a ~two-fold 522 
increase in the uncaging response amplitude (naïve = 387.8 ± 90.8 pA, n = 22 cells; 6-OHDA = 832.6 ± 110.1 523 
pA, n = 10 cells; P < 0.0001) and net charge transfer (naïve = 99.3 ± 42.9 pC, n = 22 cells; 6-OHDA = 270.8 ± 524 
60.1 pA, n = 10 cells; P < 0.0001) following chronic 6-OHDA lesion (Figure 7b–c). A modest but consistent 525 
increase in the uncaging responses was also found in dSPNs following chronic 6-OHDA lesion (naïve = 307.4 ± 526 
113.3 pA, n = 16 cells; 6-OHDA = 428.0 ± 107.4 pA, n = 10 cells; P = 0.0467) (data not shown). The increase in 527 
the uncaging responses relative to the median of their respective naïve controls was larger in iSPNs than in 528 
dSPNs (dSPNs = 1.39 ± 0.35-fold, n = 10 cells; iSPNs = 2.15 ± 0.28-fold, n = 10 cells; P = 0.0354). Altogether, 529 
these data support the involvement of postsynaptic mechanisms underlying the increased pallidostriatal 530 
response amplitude in iSPNs in the chronic 6-OHDA lesioned mice. 531 
 532 
Activation of Npas1+ GPe neurons suppresses motor output 533 
The synaptic connections to SPNs suggest that Npas1+ GPe neurons are important for motor function. This idea 534 
is consistent with recent literature showing the correlation between movements and unit activity (Dodson et 535 
al., 2015; Mallet et al., 2016). To interrogate the role of Npas1+ GPe neurons in motor output, a chemogenetic 536 
approach (Armbruster et al., 2007; Sternson & Roth, 2014) was used. Ambulatory activity of Npas1-Cre mice 537 
were assessed. Chemogenetic activation of DREADD hM3Dq-expressing Npas1+ GPe neurons with systemic 538 
administration of CNO (baseline = 6.0 ± 4.1 s, CNO = 26.4 ± 5.6 s, vehicle = 17.0 ± 4.5 s, n = 9 mice) increased 539 
the amount of time that the mice spent motionless relative to baseline (P = 0.0273). This effect was also 540 
different from vehicle control (P = 0.0039). Control Npas1-Cre (baseline = 10.2 ± 10.2 s, CNO = 5.7 ± 4.5 s, 541 
vehicle = 16.7 ± 14.1 s, n = 9 mice) showed no responsiveness to systemic administration of CNO when 542 
compared to baseline (P = 0.6406) or to vehicle (P = 0.1641). Concordantly, the effect of CNO on time spent 543 
motionless was significantly greater in Npas1-Cre mice with DREADD hM3Dq expression in the GPe than in 544 
control mice (control = 5.7 ± 4.5 s, n = 9 mice; hM3Dq = 26.4 ± 5.6 s, n = 9 mice; P = 0.0056). 545 
 546 
 547 
Discussion (1561 words) 548 
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An anatomical projection from the GPe to the dStr has been described for decades, but little is known about its 549 
connectivity pattern. In this study, we demonstrated that Npas1+ neurons provide the principal GPe input to 550 
both dSPNs and iSPNs. Following chronic dopamine lesion, there is an enhancement of the GPe input to both 551 
dSPNs and iSPNs. While the strengthening of the GPe inputs to the dSPNs arise from an increase in proximal 552 
contacts, the strengthening of the GPe inputs to the iSPNs is likely a result of an increased postsynaptic GABAA 553 
receptor expression. Activation of the GPe inputs dampens the excitability of SPNs, especially in the chronic 6-554 
OHDA lesioned state. Finally, chemogenetic activation of Npas1+ GPe neurons increases the time that the mice 555 
spend motionless. Together these data describe a novel inhibitory pathway of the basal ganglia relevant to the 556 
akinetic symptoms of PD. 557 
 558 
Npas1+ neurons constitute the principal GPe input to SPNs 559 
Altogether, the axonal arborization pattern and cell-targeting properties of the Npas1+ neurons are consistent 560 
with those of ‘arkypallidal’ GPe neurons (Mallet et al., 2012; Hegeman et al., 2016). The rabies tracing 561 
experiments demonstrated a monosynaptic connection between PV– GPe neurons and SPNs (Figure 3). While 562 
this corroborates our earlier findings (Hernandez et al., 2015), it is at odds with a previous study that showed 563 
no input from the GPe to SPNs using similar approaches (Wall et al., 2013). The reason for this discrepancy is 564 
unclear but it may be due to nuanced differences in the viral preparations. Importantly, our development of the 565 
Npas1-Cre mouse (Hernandez et al., 2015) enabled us to demonstrate that Npas1+ GPe neurons constitute the 566 
principal pallidostriatal input to both dSPNs and iSPNs. In particular, IPSC characteristics of the Npas1+ GPe-567 
SPN input (Figure 3) largely recapitulate those of the pan-GPe-SPN input (Table 2), including the increased 568 
strength of the GPe-SPN input in the chronic 6-OHDA lesioned condition (Figure 5). In contrast, PV+ neurons 569 
exhibit only limited connectivity to SPNs (Figure 3).  570 
Unlike PV+ GPe neurons, which provide a strong input to the STN, Npas1+ GPe neurons provide only a 571 
weak input to this nucleus, as indicated by the differing response amplitudes of these projections (Figure 4). 572 
This further demonstrates that Npas1+ GPe neurons exhibit the axonal arborization patterns of arkypallidal 573 
neurons (Mallet et al., 2012) and is consistent with previous findings that Foxp2 (a definitive marker for 574 
arkypallidal neurons) is expressed in the majority of Npas1+ GPe neurons (Abdi et al., 2015; Dodson et al., 575 
2015; Hernandez et al., 2015). Given the ontogenic and molecular complexity of Npas1+ neurons (Flandin et 576 
al., 2010; Nobrega-Pereira et al., 2010; Abdi et al., 2015; Dodson et al., 2015; Hernandez et al., 2015), it is 577 
possible that the STN-projecting Npas1+ neurons are a subclass of Npas1+ GPe neurons corresponding to the 578 
GPe neurons that have been shown to send axons both upstream to the dStr and downstream to the STN in 579 
single-neuron tracing studies (Bevan et al., 1998; Sato et al., 2000; Fujiyama et al., 2015). It is worthwhile to 580 
note that the Lhx6-expressing (Lhx6+) population straddles multiple classes of GPe neurons (including both 581 
Npas1+ neurons and PV+ neurons) and does not correspond to the arkypallidal neurons (Gittis et al., 2014; 582 
Abdi et al., 2015; Dodson et al., 2015; Hernandez et al., 2015; Hegeman et al., 2016). However, it remains to be 583 
seen if Npas1+-Lhx6+ GPe neurons correspond to this STN-projecting subclass of Npas1+ GPe neurons. 584 
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Moreover, our results further extend the observation that heterogeneity of GPe neuron projections exists 585 
within the STN (Xiao et al., 2015).  586 
  587 
Network activity and the GPe input in Parkinsonian mice 588 
There are several mechanisms by which Npas1+ GPe input can control motor output. First, it has been shown 589 
that activation of STN neurons is sufficient to stop action (Gittis et al., 2014). We speculate that Npas1+ GPe 590 
neurons are downstream synaptic partners of the STN and that this connection serves to suppress competing 591 
motor programs. This idea is supported by computational modeling suggesting that pallidostriatal neurons are 592 
the primary postsynaptic partners of STN neurons (Nevado-Holgado et al., 2014). While “Stop” signals from 593 
the STN lead to only transient excitation of substantia nigra pars reticulata neurons, it is thought that an 594 
additional pathway must mediate the inhibition of “Go” signals for full behavioral stopping to occur (Schmidt 595 
et al., 2013). A recent study proposed that appropriately-timed inhibition of the dStr by arkypallidal neurons 596 
may play a role in action suppression (Schmidt et al., 2013; Mallet et al., 2016). However, the postsynaptic 597 
partners and the properties of this connection were previously not known. Our present study provides the 598 
cellular correlates that mediate this signal—by inhibiting dSPNs (“Go” signals), Npas1+ GPe input likely 599 
contribute to action suppression. On the other hand, inhibition of iSPNs (“No-go” signals) by Npas1+ GPe 600 
neurons should facilitate action. It is now clear that coordinated activation of both dSPNs and iSPNs occurs 601 
during an action (Kravitz et al., 2010; Freeze et al., 2013; Calabresi et al., 2014; Sippy et al., 2015). However, 602 
additional mechanisms, such as neuromodulatory control, must exist to dictate selective inhibition of dSPNs 603 
over iSPNs (and vice versa) by Npas1+ GPe neurons. The alterations in this neuromodulatory signal in PD may 604 
contribute to motor dysfunction. 605 
In addition to action suppression, Npas1+ GPe neurons may serve as a gain control for the striatum. It 606 
has been previously demonstrated that a nonspecific inhibitory input can facilitate information processing in 607 
this manner (Laurent, 2002; Isaacson & Scanziani, 2011). It is appealing to propose that by projecting across a 608 
broad area of the striatum, Npas1+ GPe input has the potential to dampen the responses of large populations of 609 
unpreferred (i.e., weak) excitatory events onto SPNs, thus promoting the activity of SPNs that are receiving 610 
preferred (i.e., strong and well-timed) excitatory events (Burrone & Murthy, 2003; Semyanov et al., 2004; 611 
Silver, 2010) (see Hegeman et al., 2016 for further discussion). Consistent with this idea, Npas1+ GPe input 612 
synapses preferentially on dendritic regions of both dSPNs and iSPNs. This synaptic organization is similar to 613 
that formed by the local collaterals of SPNs, but contrasts with the majority of the GABAergic inputs, which 614 
synapse onto the cell body and proximal dendrites of SPNs (Wilson, 2007; Sizemore et al., 2016). In the 615 
dopamine-depleted state, iSPNs exhibit selective enhancement of the strength of their excitatory cortical input 616 
(Day et al., 2006; Peterson et al., 2012). Under these conditions, the strengthened, dendritically-targeted 617 
Npas1+ GPe input to iSPNs should counteract their increased excitatory cortical drive and correct aberrant 618 
network changes linked to motor symptoms in PD. However, as the strength of the Npas1+ GPe input to both 619 
dSPNs and iSPNs is increased following chronic 6-OHDA lesion (Figure 5), it is not clear from a parallel 620 
pathway perspective whether the alterations are likely to be beneficial or maladaptive. On the other hand, as 621 
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coactivation of dSPNs and iSPNs is required to produce desired movements (Mink, 1996; Hikosaka et al., 622 
2000; Cui et al., 2013; Tecuapetla et al., 2014), we propose that a reduction of the Npas1+ GPe input, which 623 
provides a spatially-broad inhibition of both dSPNs and iSPNs across the dStr, is permissive to the initiation 624 
and execution of somatotopically-complex motor sequences. Conversely, inappropriate strengthening of this 625 
Npas1+ GPe input to both dSPNs and iSPNs should suppress movements. This model is consistent with the 626 
finding that PD patients experience difficulty in performing volitional movements (Lang & Lozano, 1998; 627 
Dauer & Przedborski, 2003; Fahn, 2003; Redgrave et al., 2010). This idea is supported by the chemogenetic 628 
experiments in which the activation of Npas1+ GPe neurons increases the amount of time that the mice spend 629 
motionless (Figure 8). 630 
Lastly, along with targeting SPNs, this study and others have demonstrated that the pallidostriatal 631 
projection targets INTs (Bevan et al., 1998; Mallet et al., 2012; Mastro et al., 2014). It is conceivable that the 632 
GPe provides a targeted input to a subset of striatal interneurons, as suggested previously (Bevan et al., 1998; 633 
Mastro et al., 2014). As interneurons are central to network synchronization and rhythms (Freund, 2003; 634 
Berke et al., 2004; Bartos et al., 2007; Uhlhaas & Singer, 2010; Gittis et al., 2011; Allen & Monyer, 2015), 635 
future studies will be important to assess the functional alterations of the pallidostriatal input to different 636 
interneuron classes in Parkinsonian conditions. These studies will help delineate the contribution of the 637 
pallidostriatal input to the aberrant cross-coupling of different network-mediated oscillations in PD (Lopez-638 
Azcarate et al., 2010; de Hemptinne et al., 2013; Lopez-Azcarate et al., 2013; Richardson, 2013; Yang et al., 639 
2014). In particular, appropriate control of β-oscillations (13–30 Hz) is crucial for motor output. In contrast, β-640 
oscillations are prevalent in PD and their emergence correlates with the onset of hypokinetic symptoms (Kuhn 641 
et al., 2004; Gatev et al., 2006; Little et al., 2012; Stein & Bar-Gad, 2013). Increased β-oscillations are 642 
observed in the dStr in Parkinsonian conditions (Courtemanche et al., 2003; Costa et al., 2006; Moran et al., 643 
2011; Lemaire et al., 2012; Feingold et al., 2015). Computational models suggest that GABAA conductances in 644 
SPNs are important in regulating local membrane properties and, subsequently, the power of β-oscillations in 645 
the dStr (McCarthy et al., 2011; Damodaran et al., 2014; Damodaran et al., 2015). Our research findings 646 
suggest that the strengthened Npas1+ GPe-SPN input may participate directly in the exaggerated β-oscillations 647 
or indirectly via altered tuning of the local collateral and interneuron inputs within the dStr.  648 
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Figure Legends 1026 
Figure 1 | Pallidostriatal projection targets both spiny projection neurons and interneurons. (a) 1027 
Spiny projection neurons (SPNs) were identified and patch-clamped in ex vivo brain slices. An example of a 1028 
reconstructed SPN is shown. Blue (peak 450 nm) excitation wavelength was delivered locally to the external 1029 
globus pallidus (GPe) through both the 60× objective and the condenser to trigger GABA release from 1030 
pallidostriatal axons expressing the excitatory opsin, channelrhodopsin-2 (ChR2). (b) Following intrapallidal 1031 
injection of a constitutive, pan-neuronal hSyn-ChR2-eYFP adeno-associated virus (AAV), ChR2-eYFP-1032 
expressing axons (green) and boutons were observed in the dorsal striatum (dStr) under laser-scanning 1033 
confocal microscopy. The apposition of vesicular GABA transporter (magenta) is shown as white. An example 1034 
(marked with an asterisk “*”) is shown at a higher magnification in the inset. Scale bar = 1 μm. (c) Left, 1035 
representative inhibitory postsynaptic current (IPSC) recordings from a SPN (top, black) and an interneuron 1036 
(INT) (middle, gray) were shown. A paired-pulse (20 Hz) light stimulation (blue circle) was used to activate the 1037 
pan-GPe input. Traces from the two examples were overlaid and peak scaled (bottom) to illustrate the 1038 
difference in the paired-pulse ratio (PPR) and kinetics of the IPSCs observed in the two cell classes. Inset, the 1039 
relationship between whole-cell capacitance and membrane resistance of both SPNs (black) and INTs (gray) is 1040 
plotted. A photomicrograph is included to illustrate the identification of a typical SPN based on its unique 1041 
dendritic morphology. Right, summary data are presented as box plots. SPNs displayed a higher PPR (SPNs = 1042 
1.41 ± 0.23, n = 92 cells; INTs = 0.75 ± 0.16, n = 25 cells; P < 0.0001, Mann–Whitney U test), longer rise time 1043 
(SPNs = 5.9 ± 1.4 ms, n = 92 cells; INTs = 2.6 ± 1.0 ms, n = 25 cells; P < 0.0001, Mann–Whitney U test), and a 1044 
longer decay time (SPNs = 217.0 ± 44.0 ms, n = 92 cells; INTs = 177.0 ± 41.6 ms, n = 25 cells; P = 0.0277, 1045 
Mann–Whitney U test) relative to INTs. Latency was not different between SPNs and INTs (SPNs = 4.9 ± 0.6 1046 
ms, n = 12 cells; INTs = 4.3 ± 0.7 ms, n = 17 cells; P = 0.2677, Mann–Whitney U test). SPN subtypes were not 1047 
differentiated. (d) Left, current records showing the effect of SR95531 on GPe-SPN IPSCs in a representative 1048 
SPN. Right, A plot of the time course showing the sensitivity of GPe-SPN IPSCs to the application of SR95531 1049 
(horizontal bar). Medians ± median absolute deviations and two-tailed P values are listed. Medians, 1050 
interquartile ranges, and 10–90th percentiles are also presented in a graphical format. Asterisks denote 1051 
statistical significance level (*P < 0.05, ****P < 0.0001, Mann–Whitney U test and Wilcoxon signed-rank test).  1052 
 1053 
Figure 2 | Pallidostriatal projection targets fast-spiking interneurons. (a) Left, representative IPSC 1054 
recordings from a SPN (top, black) and a fast-spiking interneuron (FSI) (middle, gray) were shown. A paired-1055 
pulse (20 Hz) light stimulation (blue circle) was used to activate the pan-GPe input. Traces from the two 1056 
examples were overlaid and peak scaled (bottom) to illustrate the difference in the PPR and kinetics of the 1057 
IPSCs observed in the two cell classes. Inset, a blown-up version of the first IPSCs. (b) Summary data are 1058 
presented as box plots. SPNs displayed a higher PPR (SPNs = 1.30 ± 0.12, n = 12 cells; FSIs = 0.75 ± 0.16, n = 1059 
17 cells; P < 0.0001, Mann–Whitney U test) and a longer rise time (SPNs = 5.2 ± 0.7 ms, n = 12 cells; FSIs = 1060 
2.8 ± 1.1 ms, n = 17 cells; P = 0.0015, Mann–Whitney U test) and longer decay time (SPNs = 284.0 ± 35.9 ms, n 1061 
= 12 cells; FSIs = 195.7 ± 46.7 ms, n = 17 cells; P = 0.0051, Mann–Whitney U test) relative to SPNs. Latency 1062 
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was not different between SPNs and FSIs (SPNs = 4.9 ± 0.6 ms, n = 12 cells; FSIs = 4.3 ± 0.7 ms, n = 17 cells; P 1063 
= 0.2677, Mann–Whitney U test). For this dataset, SPNs and FSIs were both from the PV reporter 1064 
(PvalbCre;R26LSL-tdTomato) line; accordingly, SPN subtypes were not differentiated. Medians ± median absolute 1065 
deviations and two-tailed P values are listed. (c) Left, current records showing the effect of SR95531 on GPe-1066 
FSI IPSCs in a representative FSI. Right, A plot of the time course showing the sensitivity of GPe-FSI IPSCs to 1067 
the application of SR95531 (horizontal bar). Medians, interquartile ranges, and 10–90th percentiles are also 1068 
presented in a graphical format. Asterisks denote statistical significance level (**P < 0.01, ****P < 0.0001, 1069 
Mann–Whitney U test and Wilcoxon signed-rank test).  1070 
 1071 
Figure 3 | Npas1+ GPe neurons constitute the primary pallidal input to the dStr. (a) Left, a 1072 
schematic diagram of a coronal mouse brain section illustrating the location of the virus injections for 1073 
monosynaptic tracing. Drd1a-Cre and Drd2-Cre were used to target dSPNs and iSPNs, respectively. Right, a 1074 
photomicrograph showing the center of infection and mCherry-expressing, rabies virus-infected (RV-1075 
mCherry+) SPNs. (b) Top left, as a proof-of-concept, retrogradely-labeled layer 5 cortical neurons are shown. 1076 
Top right, representative retrogradely-labeled neurons (red) in the GPe. Bottom right, immunohistochemistry 1077 
for PV is shown in blue. An example of a PV+ retrogradely-labeled neuron is shown (magenta, arrowhead). 1078 
Orthogonal projections of this neurons are shown as an inset (bottom left). Scale bar = 10 µm. Two PV–, 1079 
retrogradely-labeled neurons (red) are clearly visible at the lower right corner of the field. Bottom left, a box 1080 
plot summarizing the abundance of PV+ GPe neurons retrogradely-labeled with RV-mCherry+. This is less than 1081 
the total number of PV+ neurons in the GPe as a whole (RV-mCherry+ = 0.0 ± 0.0%, n = 21 sections; total = 1082 
55.3 ± 6.2%, n = 15 sections; P < 0.0001, Mann–Whitney U test). Data from both Drd1a-Cre (4 out of 75 cells, 1083 
5.3%) and Drd2-Cre (7 out of 89 cells, 7.9%) are not significantly different (P = 0.8630) and are thus pooled. 1084 
(c) Sagittal brain sections showing the density of ChR2-eYFP-labeled GPe axons in the rostrodorsal area of the 1085 
dStr in an Npas1-Cre mouse (left) and a Pvalb-Cre mouse (right). Sections were also immunolabeled for HuCD 1086 
to decipher the cytoarchitecture. Note, the top left dark area corresponds to the external capsule. A single 1087 
confocal optical plane used illustrated in both examples. Scale bar applies to both panels in (c). (d) (Npas1+ = 1088 
18.6 ± 5.7 a.u., n = 9 ROIs; PV+ = 4.3 ± 1.2 a.u.; n = 9 ROIs, P < 0.0001, Mann–Whitney U test). (e) Response 1089 
amplitudes of the pan-, Npas1+ and PV+ GPe input to dSPNs (magenta) and iSPNs (green) are summarized in 1090 
box plots. IPSC amplitude from the PV+ GPe input was smaller relative to the Npas1+ GPe input in both dSPNs 1091 
(PV+ input = 0 ± 0 pA, n = 23 cells; Npas1+ input = 64.5 ± 21.6 pA, n = 27 cells; P < 0.0001, Mann–Whitney U 1092 
test) and iSPNs (PV+ input = 0 ± 0 pA, n = 13 cells; Npas1+ input = 138.2 ± 50.9 pA, n = 29 cells; P < 0.0001, 1093 
Mann–Whitney U test). IPSC amplitude was larger in iSPNs compared to dSPNs from both pan-GPe input 1094 
(iSPNS = 89.5 ± 41.4 pA, n = 47 cells; dSPNs = 56.9 ± 19.1 pA, n = 35 cells; P = 0.0220, Mann–Whitney U test) 1095 
and Npas1+ GPe input (dSPNs = 64.5 ± 21.6 pA, n = 27 cells; iSPNs = 138.2 ± 50.9 pA, n = 29 cells; P = 0.0002, 1096 
Mann–Whitney U test). (f) Representative recordings of Npas1+ GPe-dSPN (top, magenta) and GPe-iSPN 1097 
IPSCs (bottom, green). (g) Box plots summarizing the properties of Npas1+ GPe IPSCs in dSPN-iSPN pairs. 1098 
iSPNs exhibited larger amplitude (top left) (iSPNs = 134.1 ± 40.3 pA, dSPNs = 55.3 ± 23.5 pA, n = 17 pairs; P = 1099 
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0.0017, Wilcoxon signed-rank test) relative to dSPNs. However, there was no difference in PPR (top right) 1100 
(dSPNs = 1.18 ± 0.17; iSPNs = 1.26 ± 0.13; n = 16 pairs; P = 0.6322, Wilcoxon signed-rank test), rise time 1101 
(bottom left) (dSPNs = 5.6 ± 0.7 ms; iSPNs = 5.6 ± 1.1 ms; n = 16 pairs; P = 0.2030, Wilcoxon signed-rank test) 1102 
or decay time (bottom right) (dSPNs = 247.0 ± 50.1 ms; iSPNs = 234.1 ± 28.0 ms; n = 16 pairs; P = 0.5966, 1103 
Wilcoxon signed-rank test). (h) Left, grayscale representation of GPe-SPN IPSCs in a ‘responder’ neuron (left). 1104 
Each row represent a single trial. Blue circles and dotted lines indicate the timing of the optogenetic 1105 
stimulation of the GPe. A ‘non-responder’ neuron (right) is included for comparison. A spontaneous IPSC is 1106 
highlighted (orange arrow). Right, response rate of SPNs to different GPe inputs (Npas1+ input = 100.0 ± 0%, n 1107 
= 9 mice; PV+ input = 22.5 ± 22.5%, n = 6 mice; P = 0.0002). For simplicity, dSPNs (Npas1+ input = 27 cells, 1108 
PV+ input = 22 cells) and iSPNs (Npas1+ input = 29 cells; PV+ input = 13 cells) are pooled. Medians ± median 1109 
absolute deviations and two-tailed P values are listed. Medians, interquartile ranges, and 10–90th percentiles 1110 
are also presented in a graphical format. Asterisks denote statistical significance level (*P < 0.05, **P < 0.01, 1111 
***P < 0.001, ****P < 0.0001, Mann–Whitney U test and Wilcoxon signed-rank test).  1112 
 1113 
Figure 4 | PV+ GPe neurons constitute the primary pallidal input to the STN. (a) High-1114 
magnification images showing the spatial relationship between vesicular GABA transporter terminals 1115 
(magenta) with axons (green) from PV+ neurons (left) and Npas1+ neurons (right). Rectangular images 1116 
showing orthogonal projections. Crosshairs indicate the projected planes. Insets show high-magnification 1117 
views of areas within the squares (dotted line). Scale bar applies to both panels in (a) (b) Sample current traces 1118 
showing responsiveness of STN neurons to paired-pulse (20 Hz) optogenetic activation (blue) of PV+ GPe input 1119 
(left) and Npas1+ GPe input (right) (PV+ = 738.0 ± 409.0 pA, n = 18 cells; Npas1+ = 40.3 ± 19.1 pA, n = 16 cells; 1120 
P < 0.0001, Mann–Whitney U test). Medians ± median absolute deviations and two-tailed P values are listed. 1121 
Medians, interquartile ranges, and 10–90th percentiles are also presented in a graphical format. Asterisks 1122 
denote statistical significance level (****P < 0.0001, Mann–Whitney U test).  1123 
 1124 
Figure 5 | GPe-SPN input is enhanced in a mouse model of Parkinson’s disease. (a) Representative 1125 
pan-GPe-SPN IPSCs from naïve mice (magenta and green) and a chronic 6-OHDA lesion mouse model of 1126 
Parkinson’s disease (maroon and dark green). (b) Representative Npas1+ GPe-SPN IPSCs from naïve mice 1127 
(magenta and green) and a chronic 6-OHDA lesion mouse model of Parkinson’s disease (maroon and dark 1128 
green). (c) Left, box plots summarizing the amplitude of pan-GPe-SPN IPSCs from naïve mice (magenta and 1129 
green) and chronic 6-OHDA lesioned mice (maroon and dark green). An increase in IPSC amplitude was 1130 
observed in chronic 6-OHDA lesioned mice from both dSPNs (naïve = 56.9 ± 19.1 pA, n = 35 cells; 6-OHDA = 1131 
99.8 ± 47.2 pA, n = 19 cells; P = 0.0285, Mann–Whitney U test) and iSPNs (naïve = 89.5 ± 41.4 pA, n = 47 1132 
cells; 6-OHDA = 240.4 ± 98.8 pA, n = 36 cells; P < 0.0001, Mann–Whitney U test) compared to naïve mice. 1133 
Right, dSPN-iSPN pairs from naïve (gray, n = 11 cells) and chronic 6-OHDA lesioned mice (black, n = 12 cells). 1134 
Each symbol represents a dSPN-iSPN pair. Inset, the ratio of IPSC amplitude between dSPN-iSPN pairs in 1135 
naïve mice (gray) and chronic 6-OHDA lesioned mice (black) was calculated and denoted as ‘i-d ratio’. No 1136 
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difference in the i-d ratios of chronic 6-OHDA lesioned mice (black) and naïve mice (gray) (P = 0.1007) (d) 1137 
Left, box plots summarizing the amplitude of Npas1+ GPe-SPN IPSCs from naïve mice (magenta and green) 1138 
and chronic 6-OHDA lesioned mice (maroon and dark green). An increase in IPSC amplitude was observed in 1139 
chronic 6-OHDA lesioned mice from both dSPNs (naïve = 64.5 ± 21.6 pA, n = 27 cells; 6-OHDA = 164.7 ± 91.0 1140 
pA, n = 20 cells; P = 0.0036, Mann–Whitney U test) and iSPNs (naïve = 138.2 ± 50.9 pA, n = 29 cells; 6-OHDA 1141 
= 311.3 ± 194.2 pA, n = 29 cells; P = 0.0026, Mann–Whitney U test) compared to naïve mice. Right, 1142 
comparison of dSPN-iSPN pairs from naïve (gray, n = 16 cells) and chronic 6-OHDA lesioned mice (black, n = 1143 
14 cells). Each symbol represents a dSPN-iSPN pair. Inset, i-d ratio is not different between naïve mice (gray) 1144 
and 6-OHDA lesioned mice (black) (P > 0.9999). (e) Sample voltage traces of an iSPN from a chronic 6-OHDA 1145 
lesioned mouse. Excitability of SPNs was measured using a single current step that generated five action 1146 
potentials in the control condition (left). GPe stimulation of pallidostriatal axons suppressed iSPN firing 1147 
(middle). Terminal field stimulation (dStr stim) of pallidostriatal axons abolished iSPN firing (right, black). 1148 
This effect was reversed with co-application of SR95531 (10 μM) and picrotoxin (100 μM) (right, gray). Inset, a 1149 
representative Npas1+ GPe-iSPN IPSCs from a chronic 6-OHDA lesioned mouse showing the sensitivity of the 1150 
GPe input to a GABAA receptor antagonist, SR95531. (f) Box plots summarizing the impact of the pan-GPe 1151 
input stimulation on SPN excitability in naïve and chronic 6-OHDA lesioned mice. 6-OHDA iSPNs exhibited a 1152 
reduction in the relative firing rate compared to the effect seen in naïve iSPNs (naïve = 94.0 ± 3.1%, n = 10 1153 
cells; 6-OHDA = 85.5 ± 3.8%, n = 6 cells; P = 0.0017, Mann–Whitney U test). Similarly, 6-OHDA dSPNs also 1154 
exhibited a reduction in the relative firing compared to the response in naïve dSPNs (naïve = 95.1 ± 3.6%, n = 1155 
10 cells, 6-OHDA = 87.1 ± 3.8%, n = 6 cells; P = 0.0415, Mann–Whitney U test). Medians ± median absolute 1156 
deviations and two-tailed P values are listed. Medians, interquartile ranges, and 10–90th percentiles are also 1157 
presented in a graphical format. Asterisks denote statistical significance level (*P < 0.05, **P < 0.01, ****P < 1158 
0.0001, Mann–Whitney U test and Wilcoxon signed-rank test).  1159 
 1160 
Figure 6 | GPe input targets dendrites of dSPNs and iSPNs. (a) Top left, A single optical section 1161 
showing a representative contact formed between an eYFP+ GPe axon (green) and a SPN dendrite (magenta) in 1162 
an ex vivo slice. Square images show orthogonal x-projection (bottom) and y-projection (right). Crosshairs 1163 
indicate the projected planes. (b) Enlarged and rotated view of the x-projection (bottom) and y-projections 1164 
(top) of the GPe-SPN contact shown in a. (c) Top left, a composite micrograph of the somatodendritic 1165 
morphology of an Alexa-filled SPN in an ex vivo slice. The branch order of dendrites can be easily discerned. 1166 
Top right, graphical representation of the subcellular compartments of SPNs contacting with eYFP+ GPe axons 1167 
in naïve mice (n = 174 contacts). The majority of the contacts occur on dendrites of both dSPNs (n = 67 1168 
contacts) and iSPNs (n = 107 contacts). Bottom, a graphical representation showing the distribution of GPe-1169 
SPN contacts in naïve mice. The size of the k-means cluster (circles) denotes the relative density of contacts 1170 
(vertical lines). (d) Histogram showing the Euclidean distances of GPe-SPN contacts as a function of 1171 
eccentricity. A difference in GPe-dSPN contact location (left) between naïve (black) and chronic 6-OHDA 1172 
lesioned (gray) mice is observed (naïve = 52.0 ± 10.4 μm, n = 67 contacts; 6-OHDA = 48.4 ±9.2 μm, n = 18 1173 
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contacts; P = 0.0363, Mann–Whitney U test). Similarly, a difference in GPe-iSPN contact location (right) 1174 
between naïve (black) and chronic 6-OHDA lesioned (gray) mice is observed (naïve = 39.9 ± 15.0 μm, n = 107 1175 
contacts; 6-OHDA = 49.3 ± 14.7 μm, n = 38 contacts; P = 0.0367, Mann–Whitney U test). Medians ± median 1176 
absolute deviations and two-tailed P values are listed. (*P < 0.05, Mann–Whitney U test).  1177 
 1178 
Figure 7 | iSPNs have increased GABAA receptor surface expression following chronic 6-OHDA 1179 
lesion. (a) Transcript expression of different GABAA receptor-subunits in dSPNs (top) and iSPNs (bottom) 1180 
following chronic 6-OHDA lesion. Results are presented as fold differences relative to their respective naïve 1181 
controls. Only data for α1 (Gabra1), α2 (Gabra2), α4 (Gabra1), β1 (Gabrb1), β2 (Gabrb2), β3 (Gabrb3), γ2 1182 
(Gabra2), γ3 (Gabra3), and δ (Gabrd) are included. No data for α3 (Gabra3), α5 (Gabra5), or γ1 (Gabra1) are 1183 
presented as they have low or undetectable expression in SPNs. (b) Representative GABA-uncaging responses 1184 
(uIPSCs) in iSPNs from naïve (green, left) and chronic 6-OHDA lesioned (dark green, right) mice. (c) Box plots 1185 
summarizing the difference between naïve (green, left) and chronic 6-OHDA lesioned (dark green, right) mice 1186 
in uIPSCs amplitude (naïve = 387.8 ± 90.8 pA, n = 22 cells; 6-OHDA = 832.6 ± 110.1 pA, n = 10 cells; P < 1187 
0.0001, Mann–Whitney U test) and charge (naïve = 99.3 ± 42.9 pC, n = 22 cells; 6-OHDA = 270.8 ± 60.1 pC, n 1188 
= 10 cells; P < 0.0001, Mann–Whitney U test). Medians ± median absolute deviations and two-tailed P values 1189 
are listed. Medians, interquartile ranges, and 10–90th percentiles are also presented in a graphical format. 1190 
Asterisks denote statistical significance level (*P < 0.05, **P < 0.01, ***P < 0.001, Mann–Whitney U test and 1191 
Wilcoxon signed-rank test).  1192 
 1193 
Figure 8 | Activation of Npas1+ GPe neurons suppresses motor output. (a) Experimental setup and 1194 
timeline. Motor behavior assessed using an automated home cage scoring system. Subjects were repeatedly 1195 
tested for four consecutive weeks at one-week intervals. (b) Left, intraperitoneal (i.p.) injection of CNO (gray) 1196 
did not alter time spent motionless by control Npas1-Cre mice relative to baseline (P = 0.6406, Wilcoxon 1197 
signed-rank test) or to vehicle (P = 0.1641, Wilcoxon signed-rank test) (baseline = 10.2 ± 10.2 s, CNO = 5.7 ± 1198 
4.5 s, vehicle = 16.7 ± 14.1 s, n = 9 mice). The control group included two naïve Npas1-Cre mice and seven 1199 
sham injected Npas1-Cre mice. i.p. injection of CNO (gray) increased the amount of time that the mice spent 1200 
motionless in Npas1-Cre mice with DREADD hM3Dq AAV infection in the GPe relative to baseline (baseline = 1201 
6.0 ± 4.1 s, CNO = 26.4 ± 5.6 s, n = 9 mice; P = 0.0273, Wilcoxon signed-rank test). This effect of CNO was 1202 
reversible (CNO = 26.4 ± 5.6 s, vehicle = 17.0 ± 4.5 s, n = 9 mice; P = 0.0039, Wilcoxon signed-rank test) and 1203 
was different from CNO in control Npas1-Cre mice (P < 0.01, Mann–Whitney U test). Right, the effects of CNO 1204 
on control mice (circles) and DREADD hM3Dq mice (crosses) are shown. Each symbol represents an individual 1205 
mouse. Medians ± median absolute deviations and two-tailed P values are listed. Medians, interquartile ranges, 1206 
and 10–90th percentiles are also presented in a graphical format. Asterisks denote statistical significance level 1207 
(*P < 0.05, **P < 0.01, Mann–Whitney U test and Wilcoxon signed-rank test).  1208 
 1209 
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 Table 1. Primers sequences and weighing factors of reference genes 
 
Target Genes 
Full name Gene name Upper primer  Lower primer   
GABAA receptor α1-subunit Gabra1 ACCAGTTTCGGACCAGTTTCAGAC TGTTTAGCCGGAGCACTGTCAT 
 
GABAA receptor α2-subunit Gabra2 GTGTCATTCTGGCTGAACAGAG AGTCCATGGCAGTGGCATAA 
GABAA receptor α4-subunit Gabra4 GGGGTCCTGTTACAGAAGTGAA AGGGGTCCAAACTTTGGTGA 
GABAA receptor β1-subunit Gabrb1 GAAGATCCCTTACGTCAAAGCG TTTCTGAGGGCCTTTTCCGA 
GABAA receptor β2-subunit Gabrb2 GACAATGCAGTCACAGGAGT GGCATGTATGTCTGCAGGAT 
GABAA receptor β3-subunit Gabrb3 ACGGTCGACAAGCTGTTGAA GAGGTTGAGAGGGATCCCAGAATA 
GABAA receptor γ2-subunit Gabrg2 GAGTTCGCCAAATACATGGAG TAGAGCGATAGCAGGAGCA 
GABAA receptor γ3-subunit Gabrg3 ACAGTCGCCTTCGATTCAAC CACTCTGCATTGATAGTGAGCC 
GABAA receptor δ-subunit Gabrd GCTGTACACATACCACGTGA CAGGCTCGTCTTTAGAGCAA 
 
Reference Genes 
 
Full name Gene name Upper primer  Lower primer  
Weighting 
Factor 
Glyceraldehyde-3-phosphate 
dehydrogenase Gapdh CATTTGCAGTGGCAAAGTGG GAATTTGCCGTGAGTGGAGT 0.3216 
Cytochrome c-1 Cyc1 CATGAAGCGGCATAAGTGGT GAGGGCTGAAGGAAGATCAGAA 0.2088 
Succinate dehydrogenase 
complex, subunit A, flavoprotein 
(Fp) 
Sdha TACAAGGGACAGGTGCTGAA GCCAAAGACTACAAGGTCCAAG 0.1531 
H2A histone family, member Z H2afz AGTTGGCAGGAAATGCGT TCTTCCCGATCAGCGATTTG 0.1122 
ATP synthase, H+ transporting 
mitochondrial F1 complex, β 
subunit 
Atp5b GGCACAATGCAGGAAAGGAT ATGCCCAACTCAGCAATAGC 0.092 
Ubiquitin carboxy-terminal 
hydrolase L1 Uchl1 AAGCAGACCATCGGAAACTC ACAGCTTCTCCGTTTCAGAC 0.0863 
  1 
 Table 2. GPe-SPN IPSC properties in naïve mice 
        
 
  
P value* Median 
Median 
absolute 
deviation 
Sample size 
   
 
  
Cells Mice 
pan-GPe 
input 
Amplitude (pA) 
dSPNs 
0.0220 
56.9 19.1 35 25 
iSPNs 89.5 41.4 47 33 
 
Paired-pulse 
ratio 
dSPNs 
0.8063 
1.47 0.19 33 25 
 
iSPNs 1.41 0.25 47 33 
 
Rise time (ms) 
dSPNs 
0.7949 
6.2 1.4 33 25 
 
iSPNs 5.9 1.8 47 33 
 
Decay time (ms) 
dSPNs 
0.1387 
231.3 45.0 33 25 
 
iSPNs 202.7 33.3 47 33 
 
Latency (ms) 
dSPNs 
0.4789 
5.1 0.5 33 25 
 
iSPNs 5.1 0.8 47 33 
Npas1+ 
input 
Amplitude (pA) 
dSPNs 
0.0002 
64.5 21.6 27 9 
iSPNs 138.2 50.9 29 9 
 
Paired-pulse 
ratio 
dSPNs 
0.7938 
1.22 0.21 25 9 
 
iSPNs 1.29 0.17 28 9 
 
Rise time (ms) 
dSPNs 
0.8981 
6.1 1.3 25 9 
 
iSPNs 6.3 2.1 28 9 
 
Decay time (ms) 
dSPNs 
0.8487 
269.8 49.1 25 9 
 
iSPNs 247.5 28.2 28 9 
 
Latency (ms) 
dSPNs 
0.6611 
5.0 0.4 25 9 
 
iSPNs 5.0 0.5 28 9 
 
*Mann–Whitney test; two-tailed exact P values are shown. P values < 0.05 are shown in bold. 
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Table 3. GABAA receptor-subunit transcript levels* 
 
*Mann–Whitney test; two-tailed exact P values are shown. P values < 0.05 are shown in bold. 
 
 
 dSPNs  iSPNs 
 
Naïve  
(ΔCT, n = 6) 
6-OHDA 
(ΔCT, n = 5) 
Fold change 
(2–∆∆CT)  
P value*  
Naïve  
(ΔCT, n = 7) 
6-OHDA 
(ΔCT, n = 11) 
Fold change 
(2–∆∆CT) 
P value*
Median ± MAD  Median ± MAD Median ± MAD Median ± MAD Median ± MAD Median ± MAD 
GABAA α1  –0.57 ± 0.26 0.08 ± 0.06 0.64  ± 0.03 0.0022  –0.52 ± 0.05 –0.55 ± 0.17 1.02  ± 0.12 0.4705 
GABAA α2  2.17 ± 0.24 2.54 ± 0.28 0.77 ± 0.14 0.1797  2.40 ± 0.08 1.99 ± 0.09 1.33  ± 0.08 0.0330
GABAA α4  1.14 ± 0.22 1.83 ± 0.28 0.62 ± 0.12 0.0087  1.09 ± 0.16 1.14 ± 0.11 0.97 ± 0.07 0.7806 
GABAA β1  1.76 ± 0.18 1.66 ± 0.13 1.07 ± 0.10 0.8983  1.98 ± 0.10 1.87 ± 0.17 1.08 ± 0.12 0.1609 
GABAA β2  1.30 ± 0.08 1.58 ± 0.12 0.82 ± 0.07 0.0087  1.24 ± 0.06 1.16 ± 0.09 1.06 ± 0.06 0.5309 
GABAA β3  0.82 ± 0.09 0.75 ± 0.21 1.05 ± 0.16 0.4740  0.88 ± 0.05 0.92 ± 0.21 0.97 ± 0.13 0.9252 
GABAA γ2  1.43 ± 0.11 1.99 ± 0.16 0.68 ± 0.07 0.0043  1.44 ± 0.10 1.05 ± 0.13 1.30 ± 0.12 0.0031 
GABAA γ3  4.17 ± 0.22 3.81 ± 0.43 1.33 ± 0.40 0.3874  3.64 ± 0.12 4.26 ± 0.37 0.65 ± 0.18 0.0031 
GABAA δ  1.91 ± 0.10 1.92 ± 0.24 1.00 ± 0.18 0.8983  2.08 ± 0.04 2.41 ± 0.11 0.79 ± 0.06 0.0001
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